Paclitaxel-loaded tumor cell-derived microparticles improve radiotherapy efficacy in triple-negative breast cancer by enhancing cell killing and stimulating immunity-Reference-Cited by-同舟云学术

Paclitaxel-loaded tumor cell-derived microparticles improve radiotherapy efficacy in triple-negative breast cancer by enhancing cell killing and stimulating immunity

Published:2023-02 Issue: Volume:632 Page:122560
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Hu Xiao,Yu Li,Bian Yuan,Zeng Xiaonan,Luo Shan,Wen Qinglian,Chen Ping

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference59 articles.

1. Combining systemic therapies with radiation in breast cancer;Adamowicz;Cancer Treat. Rev.,2009

2. Adhesion molecules in radiotherapy;Baluna;Radiat. Res.,2006

3. Measures of outcome in metastatic breast cancer: insights from a real-world scenario;Bonotto;Oncologist,2014

4. Design considerations for tumour-targeted nanoparticles;Choi;Nat. Nanotechnol.,2010

5. Tailoring therapies–improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015;Coates;Ann. Oncol.,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel erythrocyte-shaped electrosprayed nanoparticles for co-delivery of paclitaxel and osimertinib: Preparation, characterization, and evaluation;European Journal of Pharmaceutics and Biopharmaceutics;2024-07

2. Extracellular vesicles derived from immune cells: Role in tumor therapy;International Immunopharmacology;2024-05

3. Advances and challenges in clinical applications of tumor cell-derived extracellular vesicles;Colloids and Surfaces B: Biointerfaces;2024-02